US 11591622
Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder
granted A61PA61P43/00A61P7/04
Quick answer
US patent 11591622 (Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder) held by Sangamo Therapeutics, Inc. expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P43/00, A61P7/04